456 related articles for article (PubMed ID: 17542756)
1. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
Oliveira ML; Arêas AP; Ho PL
Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
[TBL] [Abstract][Full Text] [Related]
2. Mucosal vaccination against bacterial respiratory infections.
Baumann U
Expert Rev Vaccines; 2008 Oct; 7(8):1257-76. PubMed ID: 18844598
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization against respiratory bacterial pathogens.
Foxwell AR; Kyd JM; Cripps AW
Expert Rev Vaccines; 2003 Aug; 2(4):551-60. PubMed ID: 14711339
[TBL] [Abstract][Full Text] [Related]
4. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
Luther P; Brachmann I; Werchan D; Wittig C; Tischner H
Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367
[TBL] [Abstract][Full Text] [Related]
5. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
Cimadamore N; Agriesti G; Testa A; Borgarello R; Capo G; Crua G
Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472
[No Abstract] [Full Text] [Related]
7. Problems and progress towards vaccination against bacterial infections of the respiratory tract.
Artenstein MS
Dev Biol Stand; 1975; 28():115-25. PubMed ID: 236208
[TBL] [Abstract][Full Text] [Related]
8. Vaccination by aerosols: modulation of clearance mechanisms in the lung.
Hensel A; Lubitz W
Behring Inst Mitt; 1997 Feb; (98):212-9. PubMed ID: 9382742
[TBL] [Abstract][Full Text] [Related]
9. NMR assays for carbohydrate-based vaccines.
Jones C
J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046
[TBL] [Abstract][Full Text] [Related]
10. Prevention of infections of the respiratory tract using the oral application of antigens.
Tischner H
Z Erkr Atmungsorgane; 1991; 176(2-3):131-7. PubMed ID: 1858413
[No Abstract] [Full Text] [Related]
11. Recent advances in the development of live, attenuated bacterial vectors.
Roland KL; Tinge SA; Killeen KP; Kochi SK
Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization for bacterial respiratory infections.
Cripps AW
Hum Vaccin; 2008; 4(6):396-9. PubMed ID: 18838872
[No Abstract] [Full Text] [Related]
13. Comparison of adjuvants for an inactivated infectious coryza vaccine.
Reid GG; Blackall PJ
Avian Dis; 1987; 31(1):59-63. PubMed ID: 3579795
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of vaccines against bacterial diseases in swine: what can we expect?
Haesebrouck F; Pasmans F; Chiers K; Maes D; Ducatelle R; Decostere A
Vet Microbiol; 2004 Jun; 100(3-4):255-68. PubMed ID: 15145504
[TBL] [Abstract][Full Text] [Related]
15. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
Riedl-Seifert RJ; van Aubel A; Kämmereit A; Elsasser U
Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
[No Abstract] [Full Text] [Related]
16. Mucosal vaccines: novel advances in technology and delivery.
Yuki Y; Kiyono H
Expert Rev Vaccines; 2009 Aug; 8(8):1083-97. PubMed ID: 19627189
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
[TBL] [Abstract][Full Text] [Related]
18. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
Gunchikov MV; Vinnikov AK
Vestn Otorinolaringol; 2001; (1):40. PubMed ID: 11247247
[No Abstract] [Full Text] [Related]
19. DNA vaccines for biodefence.
Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
[TBL] [Abstract][Full Text] [Related]
20. Is intranasal vaccination a feasible solution for tuberculosis?
Giri PK; Khuller GK
Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
